Apimeds unit MindWave signs 2-year deal with BlockAssure to build AssureChain insurance network

Apimeds Pharmaceuticals US, Inc.

MindWave Innovations, a wholly owned subsidiary of Apimeds Pharmaceuticals US (NYSE American: APUS), signed a 2-year master service agreement with BlockAssure Inc. on Oct. 4, 2026.
MindWave will build, deploy and operate AssureChain, a dedicated subnet of MindChain running BlockAssure's insurance contracts, policies, reinsurance treaties and claims on-chain.
Consideration: fixed development fee paid in quarterly installments, later O&M fees to be agreed, plus 20% of AssureCoin's total supply, fully vested on delivery, with 2-year anti-dilution.
Development is planned over four quarters against milestones; BlockAssure acceptance-tests each module, then MindWave handles hosting, validator operations, maintenance and helpdesk support.
Agreement took effect Oct. 4, 2026, auto-renews for one-year periods unless either party gives 90 days' notice; MindWave is BlockAssure's exclusive blockchain provider during the term.

This headline and bullets were generated automatically by deepseek-v4.1-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.